SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Visium Technologies, Inc. – ‘10-Q’ for 3/31/20

On:  Monday, 6/29/20, at 5:36pm ET   ·   For:  3/31/20   ·   Accession #:  1654954-20-7085   ·   File #:  0-25753   ·   Correction:  This Filing’s Metadata was Corrected ® and Changed as of 6/29/20 by the SEC on 7/7/20.

Previous ‘10-Q’:  ‘10-Q’ on 2/12/20 for 12/31/19   ·   Next:  ‘10-Q’ on 11/12/20 for 9/30/20   ·   Latest:  ‘10-Q’ on 2/20/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 6/29/20  Visium Technologies, Inc.         10-Q®       3/31/20   58:3.1M                                   Blueprint/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    388K 
 2: EX-31.1     Certification Pursuant to Rule 13A-14(A)/15D-14(A)  HTML     22K 
                Certifications Section 302 of the Sarbanes-Oxly                  
                Act of 2002                                                      
 3: EX-31.2     Certification Pursuant to Rule 13A-14(A)/15D-14(A)  HTML     22K 
                Certifications Section 302 of the Sarbanes-Oxly                  
                Act of 2002                                                      
 4: EX-32.1     Certificate Pursuant to Section 18 U.S.C. Pursuant  HTML     20K 
                to Section 906 of the Sarbanes-Oxley Act of 2002                 
 5: EX-32.2     Certificate Pursuant to Section 18 U.S.C. Pursuant  HTML     20K 
                to Section 906 of the Sarbanes-Oxley Act of 2002                 
12: R1          Document and Entity Information                     HTML     51K 
13: R2          Consolidated Balance Sheets                         HTML     95K 
14: R3          Consolidated Balance Sheets (Parenthetical)         HTML     45K 
15: R4          Consolidated Statements of Operations (Unaudited)   HTML     73K 
16: R5          Consolidated Statements of Changes in               HTML     85K 
                Stockholders' Deficit (Unaudited)                                
17: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML     96K 
18: R7          Organization, Going Concern and Basis of            HTML     32K 
                Presentation                                                     
19: R8          Summary of Significant Accounting Policies          HTML     51K 
20: R9          Derivative Liabilities                              HTML     32K 
21: R10         Accrued Interest Payable                            HTML     23K 
22: R11         Convertible Notes Payable and Note Payable          HTML     42K 
23: R12         Stockholders' Deficit                               HTML     52K 
24: R13         Stock-Based Compensation                            HTML     28K 
25: R14         Related Party Transactions                          HTML     22K 
26: R15         Commitments and Contingencies                       HTML     26K 
27: R16         Fair Value Measurement                              HTML     25K 
28: R17         Subsequent Events                                   HTML     26K 
29: R18         Summary of Significant Accounting Policies          HTML     95K 
                (Policies)                                                       
30: R19         Summary of Significant Accounting Policies          HTML     24K 
                (Tables)                                                         
31: R20         Derivative Liabilities (Tables)                     HTML     29K 
32: R21         Accrued Interest Payable (Tables)                   HTML     24K 
33: R22         Convertible Notes Payable and Note Payable          HTML     37K 
                (Tables)                                                         
34: R23         Stockholders' Deficit (Tables)                      HTML     41K 
35: R24         Stock-Based Compensation (Tables)                   HTML     26K 
36: R25         Fair Value Measurement (Tables)                     HTML     25K 
37: R26         Organization, Going Concern and Basis of            HTML     35K 
                Presentation (Details Narrative)                                 
38: R27         Summary of Significant Accounting Policies          HTML     33K 
                (Details)                                                        
39: R28         Summary of Significant Accounting Policies          HTML     22K 
                (Details Narrative)                                              
40: R29         Derivative Liabilities (Details)                    HTML     30K 
41: R30         Derivative Liabilities (Details 1)                  HTML     27K 
42: R31         Derivative Liabilities (Details Narrative)          HTML     27K 
43: R32         Accrued Interest Payable (Details)                  HTML     26K 
44: R33         Accrued Interest Payable (Details 1)                HTML     27K 
45: R34         Convertible Notes Payable and Note Payable          HTML     31K 
                (Details)                                                        
46: R35         Convertible Notes Payable and Note Payable          HTML     41K 
                (Details 1)                                                      
47: R36         Convertible Notes Payable and Note Payable          HTML     42K 
                (Details Narrative)                                              
48: R37         Stockholders' Deficit (Details)                     HTML     47K 
49: R38         Stockholders' Deficit (Details 1)                   HTML     35K 
50: R39         Stockholders' Deficit (Details Narrative)           HTML     49K 
51: R40         Stock-Based Compensation (Details)                  HTML     39K 
52: R41         Stock-Based Compensation (Details Narrative)        HTML     23K 
53: R42         Related Party Transactions (Details Narrative)      HTML     22K 
54: R43         Commitments and Contingencies (Details Narrative)   HTML     27K 
55: R44         Fair Value Measurement (Details)                    HTML     28K 
57: XML         IDEA XML File -- Filing Summary                      XML    102K 
56: EXCEL       IDEA Workbook of Financial Reports                  XLSX     67K 
 6: EX-101.INS  XBRL Instance -- vism-20200331                       XML    708K 
 8: EX-101.CAL  XBRL Calculations -- vism-20200331_cal               XML    113K 
 9: EX-101.DEF  XBRL Definitions -- vism-20200331_def                XML    232K 
10: EX-101.LAB  XBRL Labels -- vism-20200331_lab                     XML    518K 
11: EX-101.PRE  XBRL Presentations -- vism-20200331_pre              XML    421K 
 7: EX-101.SCH  XBRL Schema -- vism-20200331                         XSD     97K 
58: ZIP         XBRL Zipped Folder -- 0001654954-20-007085-xbrl      Zip     75K 


‘10-Q’   —   Quarterly Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  visiumq310-q2020v3  
 
  
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
(Mark One)
 
[X]
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2020
 
[  ]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from ___________ to ___________.
 
Commission file number 000-25753
 
VISIUM TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
 
Florida
 
87-0449667
(State of Incorporation)
 
(IRS Employer Identification No.)
 
4094 Majestic Lane, Suite 360
FAIRFAX, VA 22033
(Address of principal executive offices)
 
(703) 273-0383
Registrant’s telephone number, including area code:
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading Symbol(s)
 
Name of each exchange on which registered
None
 
None
 
None
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X] No [  ]
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes [X] No [  ]
 
Indicate by check mark whether the registrant is large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
 
Large accelerated filer
[  ]
Accelerated filer
[  ]
Non-accelerated filer
[X]
Smaller Reporting Company
[X]
Emerging growth company
[  ]
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ] No [X]
 
The number of shares outstanding of the registrant’s Common Stock, $0.0001 par value per share, as of June 27, 2020, was 1,452,260,121.
 
When used in this quarterly report, the terms “Visium,” the Company,” “we,” “our,” and “us” refer to Visium Technologies, Inc., a Florida corporation.
 
 
 C: 
 
  
CAUTIONARY STATEMENT REGARDING FORWARD LOOKING INFORMATION
 
This quarterly report on Form 10-Q contains certain forward-looking statements. Forward-looking statements may include our statements regarding our goals, beliefs, strategies, objectives, plans, including product and service developments, future financial conditions, results or projections or current expectations. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or “continue,” the negative of such terms, or other comparable terminology. These statements are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause actual results to be materially different from those contemplated by the forward-looking statements. These factors include, but are not limited to, our ability to implement our strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors. Most of these factors are difficult to predict accurately and are generally beyond our control. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. The business and operations of Visium Technologies, Inc. are subject to substantial risks, which increase the uncertainty inherent in the forward-looking statements contained in this report. Except as required by law, we undertake no obligation to release publicly the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Further information on potential factors that could affect our business is described under “Item 1A. Risk Factors” in our registration statement on Form 10-K as filed with the Securities and Exchange Commission, or the SEC, on September 27, 2019. Readers are also urged to carefully review and consider the various disclosures we have made in this report and in our Form 10-K.
 
 
 
 
 
 
 
VISIUM TECHNOLOGIES, INC. AND SUBSIDIARIES
 
INDEX
 
PART I - FINANCIAL INFORMATION
3
Item 1. Financial Statements
3
Consolidated Balance Sheets – March 31, 2020 (unaudited) and June 30, 2019
3
Consolidated Statements of Operations - Three and Nine Months ended March 31, 2020 and 2019 (unaudited)
4
Consolidated Statements of Changes in Stockholders’ Deficit (unaudited) – Three and Nine Months ended March 31, 2020 and 2019
5
Consolidated Statements of Cash Flows - Nine Months Ended March 31, 2020 and 2019 (unaudited)
7
Notes to Consolidated Financial Statements (unaudited)
8
Item 2. Management’s Discussion and Analysis and Results of Operations
20
Item 3. Quantitative and Qualitative Disclosures About Market Risk
26
Item 4. Controls and Procedures
26
PART II - OTHER INFORMATION
27
Item 1. Legal Proceedings.
27
Item 1A. Risk Factors.
27
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
27
Item 3. Defaults Upon Senior Securities.
27
Item 4. Mine Safety Disclosures.
27
Item 5. Other Information.
27
Item 6. Exhibits
27
SIGNATURES
28

 
  
2
 
 
PART I - FINANCIAL INFORMATION
 
Item 1. Consolidated Financial Statements
 
VISIUM TECHNOLOGIES, INC.
CONSOLIDATED BALANCE SHEETS
 
 
   
 
 
(Unaudited)
 
 
 
 
ASSETS
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
Cash
 $326 
 $18,668 
 
    
    
Total current assets
  326 
  18,668 
 
    
    
Total assets
 $326 
 $18,668 
 
    
    
LIABILITIES AND STOCKHOLDERS’ DEFICIT
    
    
 
    
    
Current liabilities:
    
    
Accounts payable and accrued expenses
 $282,376 
 $213,805 
Accrued compensation
  568,529 
  316,529 
Accrued interest
  661,313 
  593,838 
Convertible notes payable to ASC Recap LLC
  147,965 
  147,965 
Convertible notes payable, net of discount of $27,142 and $158,333
  897,490 
  917,095 
Notes payable
  205,000 
  205,000 
Derivative liabilities
  361,671 
  807,053 
Due to officers
  101,840 
  62,000 
Total current liabilities
 $3,226,184 
 $3,263,285 
 
    
    
Commitments and Contingencies (Note 9)
    
    
 
    
    
Stockholders’ deficit:
    
    
Preferred stock, $0.001 par value, 100,000,000 shares authorized
    
    
Series A (65,000,000 shares designated, 13,992,340 shares issued and outstanding as of March 31, 2020 and June 30, 2019)
 $13,992 
 $13,992 
Series B (30,000,000 shares designated, 1,327,640 shares issued and outstanding as of March 31, 2020 and June 30, 2019)
  1,328 
  1,328 
Series AA Convertible Stock ($0.001 par value; 1 share authorized, 1 share issued and outstanding as of March 31, 2020 and June 30, 2019)
  - 
  - 
Common stock, $0.0001 par value, 10,000,000,000 shares authorized: 326,023,957 shares issued and 323,929,510 shares outstanding as of March 31, 2020 and 45,610,716 shares issued and 42,066,269 outstanding at June 30, 2019 (See Note 6)
  32,393 
  4,207 
Additional paid in capital
  43,953,989 
  43,184,984 
Accumulated deficit
  (47,227,560)
  (46,449,128)
Total stockholders’ deficit
  (3,225,858)
  (3,244,617)
 
    
    
Total liabilities and stockholders’ deficit
 $326 
 $18,668 
 
(1) Derived from audited financial statements
 
See Notes to Unaudited Consolidated Financial Statements.
 
 
3
 
 
VISIUM TECHNOLOGIES, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
 
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
March 31,
 
   
 
   
 
2019
 
 
2020
 
 
2019
 
Net revenues
 $- 
 $- 
 $- 
 $- 
 
    
    
    
    
Operating expenses:
    
    
    
    
Selling, general and administrative
  189,675 
  1,445,550 
  604,439 
  2,573,734 
Development expense
  - 
  - 
  35,500 
  - 
Amortization expense
  - 
  50,107 
  - 
  91,863 
Total Operating Expenses
  189,675 
  1,495,657 
  639,939 
  2,665,597 
 
    
    
    
    
Loss from Operations
  (189,675)
  (1,495,657)
  (639,939)
  (2,665,597)
 
    
    
    
    
Other income (expenses):
    
    
    
    
Gain (loss) on change in fair value of derivative liabilities
  (23,319)
  (536,549)
  462,249 
  (730,804)
Derivative liability expense
  - 
  (341,423)
  (61,396)
  (341,423)
Gain (loss) on settlement of debt
  (169,060)
  2,292,162 
  (267,881)
  2,303,147 
Other income
  - 
  10,000 
  - 
  10,000 
Interest expense
  (72,190)
  (121,592)
  (271,465)
  (233,194)
Total other income (expenses)
  (264,569)
  1,302,598 
  (138,493)
  1,007,726 
 
    
    
    
    
Net loss
 $(454,244)
 $(193,059)
 $(778,432)
 $(1,657,871)
 
    
    
    
    
Loss per common share basic and diluted
 $(0.002)
 $(0.01)
 $(0.007)
 $(0.10)
 
    
    
    
    
Weighted average common shares outstanding – basic and diluted
  191,033,101 
  21,619,609 
  105,939,637 
  16,765,283 
 
See Notes to Unaudited Consolidated Financial Statements.
 
 
4
 
 
VISIUM TECHNOLOGIES, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
FOR THE THREE AND NINE MONTHS ENDED MARCH 31, 2020
(UNAUDITED)
 
For the three months ended March 31, 2020
 
 
 
Preferred Stock -Series A $0.001 Par Value
 
 
PreferredStock - Series B $0.001 Par Value
 
 
Preferred Stock - Series AA $0.001 Par Value
 
 
Common Stock $0.0001 Par Value
 
 
Additional Paid-in
 
 
Accumulated
 
 
Total Stockholders’
 
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Capital
 
 
Deficit
 
 
Deficit
 
  13,992,340 
 $13,992 
  1,327,640 
 $1,328 
  1 
 $0 
  113,850,143 
 $11,385 
 $43,603,682 
 $(46,773,316)
 $(3,142,929)
 
    
    
    
    
    
    
    
    
    
    
    
Shares issued for consulting services
    
    
    
    
    
    
  8,683,333 
  868 
  38,867 
    
  39,735 
Shares issued as compensation
    
    
    
    
    
    
  20,000,000 
  2,000 
  22,000 
    
  24,000 
Shares issued for conversion of notes payable
    
    
    
    
    
    
  181,396,034 
  18,140 
  289,440 
    
  307,580 
Net loss for the three months ended March 31, 2020
    
    
    
    
    
    
    
    
    
  (454,244)
  (454,244)
 
    
    
    
    
    
    
    
    
    
    
    
Balance at March 31, 2020
  13,992,340 
 $13,992 
  1,327,640 
 $1,328 
  1 
 $0 
  323,929,510 
 $32,393 
 $43,953,989 
 $(47,227,560)
 $(3,225,858)
 
For the Nine Months Ended March 31, 2020
 
 
 
Preferred Stock - Series A $0.001 Par Value
 
 
Preferred Stock -Series B $0.001 Par Value
 
 
Preferred Stock -Series AA $0.001 Par Value
 
 
Common Stock $0.0001 Par Value
 
 
Additional Paid-in
 
 
Accumulated
 
 
Total Stockholders’
 
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Capital
 
 
Deficit
 
 
Deficit
 
Balance at June 30, 2019
  13,992,340 
 $13,992 
  1,327,640 
 $1,328 
  1 
 $0 
  42,066,269 
 $4,207 
 $43,184,984 
 $(46,449,128)
 $(3,244,617)
 
    
    
    
    
    
    
    
    
    
    
    
Shares issued for consulting services
    
    
    
    
    
    
  19,650,000 
  1,965 
  130,770 
    
  132,735 
Shares issued as compensation
    
    
    
    
    
    
  28,000,000 
  2,800 
  49,200 
    
  52,000 
Shares issued for conversion of notes payable
    
    
    
    
    
    
  234,213,241 
  23,421 
  589,035 
    
  612,456 
Net loss for the Nine Months Ended March 31, 2020
    
    
    
    
    
    
    
    
    
  (778,432)
  (778,432)
 
    
    
    
    
    
    
    
    
    
    
    
Balance at March 31, 2020
  13,992,340 
 $13,992 
  1,327,640 
 $1,328 
  1 
 $0 
  323,929,510 
 $32,393 
 $43,953,989 
 $(47,227,560)
 $(3,225,858)
 
See Notes to Unaudited Consolidated Financial Statements.
 
 
5
 
 
VISIUM TECHNOLOGIES, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
FOR THE THREE AND NINE MONTHS ENDED MARCH 31, 2019
(UNAUDITED)
 
For the three months ended March 31, 2019
 
 
 
Preferred Stock - Series A $0.001 Par Value
 
 
Preferred Stock - Series B $0.001 Par Value
 
 
Preferred Stock - Series AA $0.001 Par Value
 
 
Common Stock $0.0001 Par Value
 
 
Additional Paid-in
 
 
Accumulated
 
 
Total Stockholders’
 
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Capital
 
 
Deficit
 
 
Deficit
 
  13,992,340 
 $13,992 
  1,327,640 
 $1,328 
  1 
 $0 
  19,450,977 
 $1,945 
 $41,891,289 
 $(46,156,008)
 $(4,247,454)
 
    
    
    
    
    
    
    
    
    
    
    
Shares issued as compensation
    
    
    
    
    
    
  20,348,601 
  2,035 
  1,177,423 
    
 $1,179,458 
Shares issued for consulting services
    
    
    
    
    
    
  1,783,339 
  178 
  87,322 
    
  87,500 
Net loss for the three months ended March 31, 2019
    
    
    
    
    
    
    
    
    
  (193,059)
  (193,059)
 
    
    
    
    
    
    
    
    
    
    
    
Balance at March 31, 2019
  13,992,340 
 $13,992 
  1,327,640 
 $1,328 
  1 
 $0 
  41,582,917 
 $4,158 
 $43,156,034 
 $(46,349,067)
 $(3,173,555)
 
For the Nine Months Ended March 31, 2019
 
 
 
Preferred Stock - Series A $0.001 Par Value
 
 
Preferred Stock -Series B $0.001 Par Value
 
 
Preferred Stock - Series AA $0.001 Par Value
 
 
Common Stock $0.0001 Par Value
 
 
Additional Paid-in
 
 
Accumulated
 
 
Total Stockholders’
 
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
 
Capital
 
 
Deficit
 
 
Deficit
 
Balance at June 30, 2018
  13,992,340 
 $13,992 
  1,327,640 
 $1,328 
  1 
 $0 
  9,376,441 
 $938 
 $40,160,699 
 $(44,691,196)
 $(4,514,240)
 
    
    
    
    
    
    
    
    
    
    
    
Shares issued as compensation
    
    
    
    
    
    
  23,427,759 
  2,343 
  1,899,157 
    
 $1,901,500 
Shares issued for consulting services
    
    
    
    
    
    
  2,750,008 
  274 
  145,226 
    
  145,500 
Shares issued for sale
    
    
    
    
    
    
  2,505,000 
  251 
  250,249 
    
  250,500 
Shares issued for conversion of notes payable
    
    
    
    
    
    
  1,985,327 
  198 
  200,857 
    
  201,055 
Acquisition of TSSG
    
    
    
    
    
    
  1,538,387 
  154 
  499,846 
    
  500,000 
Net loss for the Nine Months Ended March 31, 2019
    
    
    
    
    
    
    
    
    
  (1,657,871)
  (1,657,871)
 
    
    
    
    
    
    
    
    
    
    
    
Balance at March 31, 2019
  13,992,340 
 $13,992 
  1,327,640 
 $1,328 
  1 
 $0 
  41,582,917 
 $4,158 
 $43,156,034 
 $(46,349,067)
 $(3,173,555)
 
See Notes to Unaudited Consolidated Financial Statements.
 
 
6
 
 
VISIUM TECHNOLOGIES, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
 
 
Nine-month period ended
 
 
   
 
   
 
2019
 
Cash flows from operating activities:
 
 
 
 
 
 
Net loss
 $(778,432)
 $(1,657,871)
Adjustments to reconcile net loss to net cash used in operating activities:
    
    
(Gain) loss on change in fair value of derivative liability
  (462,249)
  730,804 
Stock-based compensation
  184,735 
  2,047,000 
Amortization of debt discount
  179,106 
  66,667 
Amortization expense
  - 
  91,863 
Derivative liability expense
  61,396 
  341,423 
(Gain) loss on extinguishment of debt
  267,881 
  (2,303,147)
Changes in operating assets and liabilities:
    
    
Accounts payable
  121,907 
  (93,106)
Prepaid insurance
  - 
  (1,646)
Accrued interest
  67,475 
  165,294 
Accrued compensation
  252,000 
  121,705 
Net cash used in operating activities
  (106,181)
  (491,014)
 
    
    
Cash flows from financing activities:
    
    
Proceeds from issuance of convertible notes payable
  48,000 
  282,500 
Proceeds from sale of common stock
  - 
  250,500 
Advances from officers, net
  39,840 
  (21,000)
 
    
    
Net cash provided by financing activities
  87,840 
  512,000 
 
    
    
Net increase (decrease0 in cash
  (18,341)
  20,986 
 
    
    
Cash, beginning of period
  18,668 
  11,412 
 
    
    
Cash, end of period
 $326 
 $32,398 
 
    
    
Supplemental disclosures of cash flow information:
    
    
Cash paid for interest
 $- 
 $1,232 
Cash paid for income taxes
 $- 
 $- 
 
    
    
Non-cash investing and financing activities:
    
    
Shares issued for acquisition
 $- 
 $500,000 
Issuance of common stock for conversion of notes payable and accrued interest (fair value of the shares issued - $612,456)
 $223,679 
 $201,055 
 
See Notes to Unaudited Consolidated Financial Statements.
 
 
7
 
 
VISIUM TECHNOLOGIES, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020
 
NOTE 1: ORGANIZATION, GOING CONCERN AND BASIS OF PRESENTATION
 
Visium Technologies, Inc. (“Visium”) was incorporated in Nevada as Jaguar Investments, Inc. during October 1987. During March 2003, a wholly owned subsidiary of the Company merged with Freight Rate, Inc., a development stage company in the logistics software business. During May 2003, the Company changed its name to Power2Ship, Inc. During October 2006, the Company merged with a newly formed, wholly owned subsidiary, Fittipaldi Logistics, Inc., a Nevada corporation, with the Company surviving but its name changed to Fittipaldi Logistics, Inc. effective November 2006. During December 2007, the Company merged with a newly formed, wholly owned subsidiary, NuState Energy Holdings, Inc., a Nevada corporation, with the Company surviving but renamed NuState Energy Holdings, Inc. effective December 2007. In October 2015 the Company redomiciled from Nevada and became a Florida corporation. In March 2018 the Company changed its name to Visium Technologies, Inc.
 
Visium is a provider of cyber security visualization, analytics and automation. Visium operates in the traditional cyber security space, as well as in the cloud-based technology and Internet of Things spaces. Visium provides cybersecurity technology solutions, tools and services to support commercial enterprises and government’s ability to protect their data. Visium’s CyGraph technology provides visualization, advanced cyber monitoring intelligence, data modeling, analytics and automation to help reduce risk, simplify cyber security and deliver better security outcomes.
 
In March 2019, Visium entered into a software license agreement with MITRE Corporation to license a patented technology, known as CyGraph, a tool for cyber warfare analytics, visualization and knowledge management. CyGraph provides advanced analytics for cybersecurity situational awareness that is scalable, flexible and comprehensive.
 
Going Concern
 
The accompanying financial statements have been prepared on a going concern basis. For the nine months ended March 31, 2020 we had a net loss of $778,432, had net cash used in operating activities of $106,181, and had negative working capital of $3,225,858. These matters raise substantial doubt about the Company’s ability to continue as a going concern for a period of one year from the date of this filing. The Company’s ability to continue as a going concern is dependent upon its ability to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due, to fund possible future acquisitions, and to generate profitable operations in the future. Management plans to provide for the Company’s capital requirements by continuing to issue additional equity and debt securities. The outcome of these matters cannot be predicted at this time and there are no assurances that, if achieved, the Company will have sufficient funds to execute its business plan or generate positive operating results. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
 
A novel strain of coronavirus, the COVID-19 virus, may adversely affect our business operations and financial condition.
 
In December 2019, an outbreak of the COVID-19 virus was reported in Wuhan, China. On March 11, 2020, the World Health Organization declared the COVID-19 virus a global pandemic and on March 13, 2020, President Donald J. Trump declared the virus a national emergency in the United States. This highly contagious disease has spread to most of the countries in the world and throughout the United States, creating a serious impact on customers, workforces and suppliers, disrupting economies and financial markets, and potentially leading to a world-wide economic downturn. It has caused a disruption of the normal operations of many businesses, including the temporary closure or scale-back of business operations and/or the imposition of either quarantine or remote work or meeting requirements for employees, either by government order or on a voluntary basis. The pandemic may adversely affect our potential customers’ operations, our employees and our employee productivity. It may also impact the ability of our subcontractors, partners, and suppliers to operate and fulfill their contractual obligations, and result in an increase in costs, delays or disruptions in performance. These supply chain effects, and the direct effect of the virus and the disruption on our employees and operations, may negatively impact both our ability to meet customer demand and our revenue and profit margins. Our employees are working remotely and using various technologies to perform their functions. We might experience delays or changes in customer demand, particularly if customer funding priorities change. Further, in reaction to the spread of COVID-19 in the United States, many businesses have instituted social distancing policies, including the closure of offices and worksites and deferring planned business activity. The disruption and volatility in the global and domestic capital markets may increase the cost of capital and limit our ability to access capital. Both the health and economic aspects of the COVID-19 virus are highly fluid and the future course of each is uncertain. For these reasons and other reasons that may come to light if the coronavirus pandemic and associated protective or preventative measures expand, we may experience a material adverse effect on our business operations, revenues and financial condition; however, its ultimate impact is highly uncertain and subject to change.
 
The board of directors and management of Visium Technologies, Inc., a Florida corporation (the “Company”), determined that, in light of the circumstances and uncertainty surrounding the effects of the COVID-19 coronavirus pandemic on the Company’s business, employees, consultants and service providers, the Company delayed the filing of its quarterly report on Form 10-Q for the period ended March 31, 2020 (the “Quarterly Report”) by up to 45 days in accordance with the SEC’s March 25, 2020 Order (Release No. 34-88465) (the “Order”), which allowed for the delay of certain filings required under the Securities and Exchange Act of 1934, as amended.  As a result, the Company is filing its Quarterly Report by no later than June 29, 2020, 45 days after the original due date of its Quarterly Report. 
 
Basis of Presentation
 
The unaudited interim consolidated financial information furnished herein reflects all adjustments, consisting only of normal recurring items, which in the opinion of management are necessary to fairly state Visium Technologies, Inc.’s (the “Company” or “we”, “us” or “our”) financial position, results of operations and cash flows for the dates and periods presented and to make such information not misleading. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted pursuant to rules and regulations of the Securities and Exchange Commission (“SEC”), nevertheless, management of the Company believes that the disclosures herein are adequate to make the information presented not misleading.
 
These unaudited consolidated financial statements should be read in conjunction with the Company’s audited financial statements for the year ended June 30, 2019, contained in the Company’s Annual Report on Form 10-K filed with the SEC on September 27, 2019. The results of operations for the nine months ended March 31, 2020, are not necessarily indicative of results to be expected for any other interim period or the fiscal year ending June 30, 2020.
  
 
8
 
 
VISIUM TECHNOLOGIES, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
 MARCH 31, 2020
 
NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Fiscal Year
 
The fiscal year ends on June 30. References to fiscal year 2020, for example, refer to the fiscal year ending June 30, 2020.
 
Principles of Consolidation
 
The accompanying consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles and include the accounts of the Company and its wholly-owned subsidiaries, Visium Analytics, LLC, and Threat Surface Solutions Group, LLC. All significant intercompany transactions and balances have been eliminated in consolidation.
 
Use of Estimates
 
The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions used in Cox, Ross & Rubinstein Binomial Tree stock-based compensation valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate and in the valuation allowance of deferred tax assets, and derivative liabilities.
 
Cash and Cash Equivalents
 
The Company considers all highly liquid, temporary, cash equivalents or investments with an original maturity of three months or less when purchased, to be cash equivalents. The Company had no cash equivalents during the nine months ended March 31, 2020 and June 30, 2019.
 
Concentration of Credit Risks
 
The Company is subject to a concentration of credit risk from cash.
 
The Company’s cash account is held at a financial institution and is insured by the Federal Deposit Insurance Corporation, or FDIC, up to $250,000. During the nine months ended March 31, 2020 and 2019, the Company had not reached a bank balance exceeding the FDIC insurance limit.
 
Convertible Instruments and Derivative Liabilities
 
The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with ASC 470-20, Debt with Conversion and Other Options. Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.
 
ASC 815-40, Contracts in Entity’s own Equity, generally provides that, among other things, if an event is not within the entity’s control, such contract could require net cash settlement and shall be classified as an asset or a liability.
 
The Company assessed the potential classification of its derivative financial instruments as of March 31, 2020 and June 30, 2019, which consist of convertible instruments and rights to shares of the Company’s common stock, and determined that such derivatives meet the criteria for liability classification under ASC 815.
 
 
9
 
 
VISIUM TECHNOLOGIES, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
 MARCH 31, 2020
 
NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, continued
 
ASC 815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract; (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur; and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be conventional, as described.
 
Fair Value of Financial Instruments
 
The Company accounts for assets and liabilities measured at fair value on a recurring basis, in accordance with ASC Topic 820, Fair Value Measurements and Disclosures, or ASC 820. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements, establishes a framework for measuring fair value, and expands disclosure about such fair value measurements.
 
ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:
 
Level 1:
Observable inputs such as quoted market prices in active markets for identical assets or liabilities.
 
 
Level 2:
Observable market-based inputs or unobservable inputs that are corroborated by market data.
 
 
Level 3:
Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.
 
Additional Disclosures Regarding Fair Value Measurements
 
The carrying value of cash, accounts payable and accrued expenses, accrued compensation, notes payable and convertible promissory notes payable, approximate their fair value due to the short maturity of these items or the use of market interest rates.
 
Business combinations
 
Business combinations are accounted for at fair value. Acquisition costs are expensed as incurred and recorded in selling, general and administrative expenses. The accounting for business combinations requires estimates and judgment as to expectations for future cash flows of the acquired business, and the allocation of those cash flows to identifiable intangible assets, in determining the estimated fair value for assets acquired and liabilities assumed. The fair values assigned to tangible and intangible assets acquired and liabilities assumed, including contingent consideration, are based on management’s estimates and assumptions, as well as other information compiled by management, including valuations that utilize customary valuation procedures and techniques. If the actual results differ from the estimates and judgments used in these estimates, the amounts recorded in the financial statements could result in a possible impairment of the intangible assets and goodwill, require acceleration of the amortization expense of finite-lived intangible assets, or the recognition of additional consideration which would be expensed. The fair value of contingent consideration is remeasured each period based on relevant information and changes to the fair value are included in the operating results for the period.
 
 
10
 
 
VISIUM TECHNOLOGIES, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
 MARCH 31, 2020
 
NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, continued
 
Revenue Recognition
 
Effective July 1, 2018, the Company adopted the requirements of ASU 2014-09 (ASC 606- Revenue from contracts with Customers). The underlying principle of the new standard is that a business or other organization will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects what it expects to receive in exchange for the goods or services. The Company has not yet earned any revenue to date and will recognize future revenues in accordance with this standard. All revenues will be recognized when: (i) a contract with a client has been identified, (ii) the performance obligation(s) in the contract have been identified, (iii) the transaction price has been determined, (iv) the transaction price has been allocated to each performance obligation in the contract, and (v) the Company has satisfied the applicable performance obligation over time or at a point in time.
 
Income Taxes
 
The Company accounts for income taxes pursuant to the provisions of ASC 740-10, “Accounting for Income Taxes,” which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.
 
The Company follows the provisions of ASC 740-10, “Accounting for Uncertain Income Tax Positions”. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The Company believes its tax positions are all highly certain of being upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.
 
The Company has adopted ASC 740-10-25, Definition of Settlement”, which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion of an examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. As of June 30, 2019, the Company had not filed tax returns for the tax years ending June 30, 2008 through 2019 and such returns, when filed, potentially will be subject to audit by the taxing authorities for a minimum of three years beyond the filing date under the three-year statute of limitations. The Company has not accrued any potential tax penalties associated with not filing these tax returns. Due to recurring losses, management believes such potential tax penalties, if any, would not be material in amount.
 
Share-Based Payments
 
The Company accounts for stock-based compensation in accordance with ASU 2019-07, Compensation – Stock Compensation (Topic 718). This update is intended to reduce cost and complexity and to improve financial reporting for share-based payments issued to non-employees (for example, service providers, external legal counsel, suppliers, etc.). The ASU expands the scope of Topic 718, Compensation—Stock Compensation, which currently only includes share-based payments issued to employees, to also include share-based payments issued to non-employees for goods and services. Consequently, the accounting for share-based payments to non-employees and employees will be substantially aligned.
 
Under ASC Topic 718, “Compensation - Stock Compensation”. Under the fair value recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.
 
The Company has elected to use the Cox, Ross & Rubinstein Binomial Tree valuation model to estimate the fair value of its options, which incorporates various subjective assumptions including volatility, risk-free interest rate, expected life, and dividend yield to calculate the fair value of stock option awards. Compensation expense recognized in the statements of operations is based on awards ultimately expected to vest and reflects estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.
 
Segment Reporting
 
The Company operates in one business segment which technologies are focused on cybersecurity.
 
 
11
 
 
VISIUM TECHNOLOGIES, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
 MARCH 31, 2020
 
NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, continued
 
Recent Accounting Pronouncements
 
In May 2018, the FASB issued ASU No. 2019-05, Income Taxes (Topic 740): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 118, regarding the accounting implications of the recently issued Tax Cuts and Jobs Act (the “Act”). This standard is effective immediately. The update clarifies that in a company’s financial statements that include the reporting period in which the Act was enacted, the company must first reflect the income tax effects of the Act in which the accounting under GAAP is complete. These amounts would not be provisional amounts. The company would also report provisional amounts for those specific income tax effects for which the accounting under GAAP is incomplete, but a reasonable estimate can be determined. The Company has recorded a provisional amount which it believes is a reasonable estimate of the effects of the Act on the Company’s financial statements as of March 31, 2020. Technical corrections or other forthcoming guidance could change how the Company interprets provisions of the Act, which may impact its effective tax rate and could affect its deferred tax assets, tax positions and/or its tax liabilities.
 
Basic and Diluted Earnings Per Share
 
Basic earnings per share are calculated by dividing income available to stockholders by the weighted-average number of shares of Common Stock outstanding during each period. Diluted earnings per share are computed using the weighted average number of shares of Common Stock and the dilutive Common Stock share equivalents outstanding during the period. Dilutive Common Stock share equivalents consist of shares issuable upon the exercise of in-the-money stock options and warrants (calculated using the modified-treasury stock method) and conversion of other securities such as convertible debt or convertible preferred stock. Potential dilutive common shares would be as follows:
 

 
 
March 31,
 
   
 
   
 
2019
 
Weighted average common shares outstanding
  105,939,637 
  22,992,865 
Effect of dilutive securities-when applicable:
    
    
Convertible promissory notes
  676,820,102 
  14,604,829 
Preferred Stock
  13,996,767 
  13,996,767 
Warrants
  500,000 
  500,000 
Adjusted weighted-average shares and assumed conversions
  797,256,506 
  52,094,461 
 
12
 
 
VISIUM TECHNOLOGIES, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
 MARCH 31, 2020
 
NOTE 3: DERIVATIVE LIABILITIES
 
Derivative liability - warrants 
The Company issued warrants in connection with convertible notes payable which were issued in January 2019. These warrants have price protection provisions that allow for the reduction in the exercise price of the warrants in the event the Company subsequently issues stock or securities convertible into stock at a price lower than the $0.15 per share exercise price of the warrants. Simultaneously with any reduction to the exercise price, the number of shares of common stock that may be purchased upon exercise of each of these warrants shall be increased or decreased proportionately, so that after such adjustment the aggregate exercise price payable for the adjusted number of warrants shall be the same as the aggregate exercise price in effect immediately prior to such adjustment. Because it is indeterminate whether there is a sufficient number of authorized and unissued shares exists at the assessment date, the Company calculates a derivative liability associated with the warrants in accordance with FASB ASC Topic 815-40-25.
 
Accounting for Derivative Warrant Liability 
The Company’s derivative warrant instruments have been measured at fair value at March 31, 2020 using the Cox, Ross & Rubinstein Binomial Tree valuation model. The Company recognizes the derivative liability related to those warrants that contain price protection features in its consolidated balance sheet as liabilities. The liability is revalued at each reporting period and changes in fair value are recognized currently in the consolidated statements of operations. The initial recognition and subsequent changes in fair value of the derivative warrant liability have no effect on the Company’s cash flows.
 
Derivative liability – convertible notes 
The Company has certain convertible notes with variable price conversion terms. Upon the issuance of these convertible notes and as a consequence of their conversion features, the convertible notes give rise to derivative liabilities. The Company’s derivative liabilities related to its convertible notes payable have been measured at fair value at March 31, 2020 and June 30, 2019 using the Cox, Ross & Rubinstein Binomial Tree valuation model.
 
The revaluation of the warrants and convertible debt at each reporting period, as well as charges associated with issuing additional convertible notes, and warrants with price protection features, resulted in the recognition of a gain of $462,249 and a loss of $730,804 for the nine months ended March 31, 2020 and 2019, respectively in the Company’s consolidated statements of operations, under the caption “Gain (loss) on change in fair value of derivative liabilities”. The fair value of the warrants at March 31, 2020 and June 30, 2019 was $350 and $37,200, respectively. The fair value of the derivative liability related to the convertible debt at March 31, 2020 and June 30, 2019 is $361,671 and $807,053, respectively, which is reported on the consolidated balance sheet under the caption “Derivative liability”The Company accounts for the conversions of the notes at fair valu and records the difference as Gain (Loss) on settlement of debt in the Income Statement.
 
The Company has determined its derivative liability to be a Level 3 fair value measurement. The significant assumptions used in the Cox, Ross & Rubinstein Binomial Tree valuation of the derivative are as follows:
 
 
 
Nine Months Ended March 31,
 
 
 
2020  
 
2019
 
Effective exercise price
 
$
0.00049 - $ 0.0033
 
 
$
0.0216 - 0.0616
 
Effective market price
 
$
.009
 
 
$
0.08
 
Volatility
 
 
223% - 521
%
 
 
222.61
%
Risk-free interest
 
 
0.05% - 1.68
%
 
 
2.40% - 2.43
%
Terms
 
 
30 - 650 days
 
 
 
30-286 days
 
Expected dividend rate
 
 
0.00
%
 
 
0.00
%
 
Changes in the derivative liabilities during the Nine Months Ended March 31, 2020 is follows:
 
Derivative liability at June 30, 2019
 $807,053 
Derivative liability reduced as a result of note conversions
  (92,529)
Increase due to issuance of convertible note
  109,396 
Gain on change in fair value of derivative liability
  (462,249)
Derivative liability at March 31, 2020
 $361,671 
 
NOTE 4: ACCRUED INTEREST PAYABLE
 
Changes in accrued interest payable during the Nine Months Ended March 31, 2020 is as follows:
 
Accrued interest payable at June 30, 2019
 $593,838 
Interest expense accrued for the nine months ended March 31, 2020
  92,359 
Conversion of accrued interest into common stock
  (24,884)
Accrued interest payable at March 31, 2020
 $661,313 
 
Interest expense for the nine months ended March 31, 2020 was comprised of the following:
 
Interest expense for the nine months ended March 31, 2020
 $92,359 
Amortization of debt discount
  179,106 
Total interest expense for the nine months ended March 31, 2020
 $271,465 
  
 
13
 
 
VISIUM TECHNOLOGIES, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020
 
NOTE 5: CONVERTIBLE NOTES PAYABLE AND NOTE PAYABLE
 
Convertible Notes Payable
 
At March 31, 2020 and June 30, 2019 convertible debentures consisted of the following:
 
 
 
March 31,
 
   
 
   
 
2019
 
Convertible notes payable
 $924,632 
 $1,075,428 
Discount on convertible notes
  (27,142)
  (158,333)
Convertible notes, net
  897,490 
  917,095 
 
    
    
Convertible notes payable to ASC Recap
  147,965 
  147,965 
Total
 $1,045,455 
 $1,065,060 
 
The Company had convertible promissory notes aggregating approximately $1.05 million and $1.06 million at March 31, 2020 and June 30, 2019, respectively. The related accrued interest amounted to approximately $486,000 and $430,000 at December 30, 2019 and June 30, 2019, respectively. The convertible notes payable bear interest at rates ranging from 0% to 18% per annum. The convertible notes are generally convertible, at the holders’ option, at rates ranging from $0.0012 to $22,500 per share, as a result of the two reverse stock splits. At March 31, 2020, $890,000 of convertible promissory notes had matured, are in default and remain unpaid.
 
On July 22, 2013 and May 6, 2014, the Company issued to ASC Recap LLC (“ASC”) two convertible promissory notes with principal amounts of $25,000 and $125,000, respectively. These two notes were issued as a fee for services under a 3(a)10 transaction. While the Company continues to carry the balance of these notes on its balance sheet, management is disputing the notes and does not believe that the balances of these notes are owed. See Note 9 – Commitments and Contingencies in the footnotes to the financial statements. The July 22, 2013 note matured on March 31, 2014 and a balance of $22,965 remains unpaid. The May 6, 2014 note matured on May 6, 2016 and remains unpaid. The notes are convertible into the common stock of the Company at any time at a conversion price equal to (i) 50% of the lowest closing bid price of our common stock for the twenty days prior to conversion or (ii) fixed price of $0.15 or $0.30 per share.
 
For the nine months ended March 31, 2020, the following summarizes the conversion of debt for common shares:
 
 
 
 
 
 
Amount
 
 
 
 
 
 
 
 
Adjustment
 
 
 
 
 
Conversion
 
 
 
Shares
 
 
Converted
 
 
 
 
 
Conversion
 
 
to
 
 
 
 
 
Price
 
Name
 
Issued
 
 
Principal
 
 
Interest
 
 
Expense
 
 
Fair Value
 
 
Total
 
 
Per Share
 
FirstFire Global Opportunities Fund LLC
  106,613,286 
 $108,116 
 $- 
 $14,200 
 $128,723 
 $251,039 
 $0.00235 
Auctus Funds, LLC
  116,698,824 
  57,779 
  17,177 
  14,250 
  207,893 
  297,100 
 $0.00255 
Mark Lucky
  10,901,131 
  32,900 
  7,707 
  - 
  23,710 
  64,317 
 $0.00590 
TOTAL
  234,213,241 
 $198,795 
 $24,884 
 $28,450 
 $360,326 
 $612,456 
 $0.00261 
 
Covenants and Other Matters
 
Certain of our convertible loan agreements contain customary covenants and events of default and termination, including cross-default provisions, whereby a default under one loan and security agreement triggers a default under those certain other convertible notes. The Auctus Funds note has a provision whereby a default annual interest rate of 24% applies after the one year anniversary of the note, and the FirstFire note has a provision whereby the default annual interest rate of 15% applies after the one year anniversary of the note, both of which occurred in January, 2020.  The Auctus Funds note contains a 150% payoff provision if the note is in default, and is due and payable only when the Company receives a notice of default from the noteholder.  As of March 31, 2020 and subsequently, the Company has not received any notice of default.
 
Notes Payable
 
The Company had promissory notes aggregating $205,000 at March 31, 2020 and June 30, 2019, respectively. The related accrued interest amounted to approximately $171,000 and $159,000 at March 31, 2020 and June 30, 2019, respectively. The notes payable bear interest at rates ranging from 8% to 16% per annum which is payable monthly. All promissory notes outstanding as of March 31, 2020 have matured, are in default, and remain unpaid.
 
 
14
 
 
VISIUM TECHNOLOGIES, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020
 
NOTE 6: STOCKHOLDERS’ DEFICIT
 
Common Stock
 
At March 31, 2020, the Company had 10,000,000,000 authorized common shares.
 
Issuances of Common Stock During the Nine Months Ended March 31, 2020
 
Convertible Notes Payable
 
During the nine months ended March 31, 2020 the Company issued 234,213,241 shares of its common stock related to the conversion of $223,679 of principal and accrued interest of its convertible notes payable, at an average contract conversion price of $0.00095 per share.  The fair value of the shares issued was $612,456.
 
Stock Based Compensation and Stock Based Consulting Services Expense
 
During the nine months ended March 31, 2020 the Company issued 19,650,000 shares of its $0.0001 par value common stock to five consultants, as compensation for services rendered. The shares were valued at $132,735, or $0.006 per share.
 
During the nine months ended March 31, 2020 the Company issued 28,000,000 shares of its $0.0001 par value common stock to two of our Directors, as compensation for services rendered. The shares were valued at $52,000, or $0.00186 per share.
 
Issuances of Common Stock During the Nine Months Ended March 31, 2019
 
Convertible Notes Payable
 
During the nine months ended March 31, 2019 the Company issued 1,985,327 shares of its common stock related to the conversion of $201,055 of principal and accrued interest of its convertible notes payable, at an average contract conversion price of $0.101 per share.
 
Sale of Restricted Common Stock
 
During the nine months ended March 31, 2019 the Company issued 2,505,000 shares of its common stock related to the sale of its common stock resulting in proceeds of $250,500, at an average price of $0.10 per share.
 
Acquisition of Threat Surface Solutions Group, LLC
 
During the nine months ended March 31, 2019 the Company issued 1,538,387 shares of its common stock related to its acquisition of Threat Surface Solutions Group, LLC, valued at $500,000, or an average price of $0.325 per share.
 
Stock Based Compensation
 
During the nine months ended March 31, 2019 the Company issued 23,427,759 shares of its $0.0001 par value common stock as compensation to its directors and officers related to the vesting of restricted stock grants. The shares were valued at $1,901,500, or $0.081 per share, based on the share price at the time of the transactions.
 
During the nine months ended March 31, 2019 the Company issued and vested 2,750,008 shares of its $0.0001 par value common stock to four consultants, as compensation under four separate consulting agreements. The shares were valued at $145,500, or $0.052 per share, based on the share price at the time of the transactions.
 
 
15
 
 
VISIUM TECHNOLOGIES, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020
 
NOTE 6: STOCKHOLDERS’ DEFICIT, continued
 
Preferred Stock
The Series A and B issued and outstanding shares of the Company’s convertible preferred stock have a par value of $0.001. All classes rank(ed) prior to any class or series of the Company’s common stock as to the distribution of assets upon liquidation, dissolution or winding up of the Company or as to the payment of dividends. All preferred stock shall have no voting rights except if the subject of such vote would reduce the amount payable to the holders of preferred stock upon liquidation or dissolution of the company and cancel and modify the conversion rights of the holders of preferred stock as defined in the certificate of designations of the respective series of preferred stock.
 
Series A Convertible Preferred Stock
The Series A Preferred Stock has a stated value of $750.00 per share. Each one share of Series A Preferred Stock is convertible into one (1) share of Common Stock. In the event the Common Stock price per share is lower than $0.10 (ten cents) per share then the Conversion shall be set at $0.035 per share. The Common Stock shares are governed by Lock-Up/Leak-Out Agreements.
 
Series B Convertible Preferred Stock
Thirty million (30,000,000) shares of preferred stock were designated as a new Series B Preferred stock in April 2016. This Series B Preferred Stock has a $0.001 par value, and each 300 shares is convertible into one share of the Company’s common stock, with a stated value of $375 per share.
 
Series AA Convertible Preferred Stock
In March 2018, the Company authorized and issued one share of Series AA convertible preferred stock which provides for the holder to vote on all matters as a class with the holders of Common Stock and each share of Series AA Convertible Preferred Stock shall be entitled to 51% of the common votes on any matters requiring a shareholder vote of the Company. Each one share of Series AA Convertible Preferred Stock is convertible into one (1) share of Common Stock. Mark Lucky, our CEO, is the holder of the one share of Series AA Convertible Preferred Stock.
 
Common Stock Warrants
In January 2019 we issued 500,000 warrants with a three-year life and a conversion price of $0.15 per share. These warrants have price protection provisions that allow for the reduction in the current exercise price upon the occurrence of certain events, including the Company’s issuance of common stock or securities convertible into or exercisable for common stock, such as options and warrants, at a price per share less than the exercise price then in effect. For instance, if the Company issues shares of its common stock or options exercisable for or securities convertible into common stock at an effective price per share of common stock less than the exercise price then in effect, the exercise price will be reduced to the effective price of the new issuance. Simultaneously with any reduction to the exercise price, the number of shares of common stock that may be purchased upon exercise of each of these warrants shall be increased proportionately, so that after such adjustment the aggregate exercise price payable for the adjusted number of warrants shall be the same as the aggregate exercise price in effect immediately prior to such adjustment.
 
A summary of the status of the Company’s outstanding common stock warrants as of March 31, 2020 and changes during the nine months ending on that date is as follows:
 
 
 
Number of
 
 
Weighted Average
 
 
 
Warrants
 
 
Exercise Price
 
Common Stock Warrants
 
 
 
 
 
 
Balance at beginning of year
  500,000 
 $0.15 
Granted
  - 
    
Granted due to repricing
  - 
  - 
Exercised
  - 
  - 
Forfeited
  - 
  - 
Balance at end of period
  500,000 
 $0.15 
 
    
    
Warrants exercisable at end of period
  500,000 
 $0.15 
 
    
    
Weighted average fair value of warrants granted during the period
    
 $950 
 
 
16
 
 
VISIUM TECHNOLOGIES, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020
 
NOTE 6: STOCKHOLDERS’ DEFICIT, continued
 
The following table summarizes information about common stock warrants outstanding at March 31, 2020:
 
 
 
 
Warrants Outstanding
 
 
Warrants Exercisable
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Average
 
Weighted
 
 
 
 
 
Weighted
 
Range of
 
 
Number
 
 
Remaining
 
Average
 
 
Number
 
 
Average
 
Exercise
 
 
Outstanding at
 
 
Contractual
 
Exercise
 
 
Exercisable at
 
 
Exercise
 
Price
 
 
 
 
Life
 
Price
 
 
 
 
Price
 
$
0.15
 
 
 
500,000
 
 
1.78 Years
 
$
0.15
 
 
 
500,000
 
 
$
0.15
 
 
 
 
 
 
500,000
 
 
1.78 Years
 
$
0.15
 
 
 
500,000
 
 
$
0.15
 
 
NOTE 7 - STOCK-BASED COMPENSATION
 
Restricted Stock Awards
 
Restricted stock awards are awards of common stock that are subject to restrictions on transfer and to a risk of forfeiture if the holder leaves the Company before the restrictions lapse. The holder of a restricted stock award is generally entitled at all times on and after the date of issuance of the restricted shares to exercise the rights of a shareholder of the Company, including the right to vote the shares. The value of stock awards that vest over time was established by the market price on the date of its grant. A summary of the Company’s restricted stock activity for the Nine Months Ended March 31, 2020 is presented in the following table:
 
 
 
For the Nine Months Ended
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
Average
 
 
 
 
 
 
Grant Date
 
 
 
Shares
 
 
Fair Value
 
Unvested at beginning of period
  3,544,447 
 $0.06 
Granted
  - 
 $- 
Forfeited
  - 
  - 
Vested
  (1,450,000)
 $0.06 
Unvested at end of period
  2,094,447 
 $0.06 
 
Unrecognized compensation expense related to outstanding restricted stock awards to employees and directors as of March 31, 2020 was $125,666 and is expected to be recognized over a weighted average period of 1.08 years.
  
 
17
 
 
VISIUM TECHNOLOGIES, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020
 
NOTE 8: RELATED PARTY TRANSACTIONS
 
Equity transactions with related parties are described in Note 6.
 
From time to time we have borrowed operating funds from Mr. Mark Lucky, our Chief Executive Officer and from certain Directors, for working capital. The advances were payable upon demand and were interest free. At March 31, 2020 there was $101,840 outstanding of such advances made to the Company.
 
NOTE 9: COMMITMENTS AND CONTINGENCIES
 
Contingencies
 
The Company accounts for contingent liabilities in accordance with Accounting Standards Codification (“ASC”) Topic 450, Contingencies. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of March 31, 2020, and based on the assessment there are no probable loss contingencies requiring accrual or disclosures within its financial statements.
 
License Contingent Consideration
 
Our license agreements with the sellers of Threat Surface Solutions Group, LLC includes a provision for a royalty payment based on ten percent (10%) of sales generated by Threat Surface Solutions Group beginning on the Agreement Date and ending on October 12, 2021, capped at a maximum royalty of $2,500,000. As of March 31, 2020 we have not generated any revenue related to these license agreements.
 
Our license agreements with George Mason University and The MITRE Corporation include provisions for a royalty payment on revenues collected of 5% and 5%, respectively. As of March 31, 2020 we have not generated any revenue related to these license agreements.
 
Legal Claims
 
In July 2018 the Company was named as the defendant in a legal proceeding brought by Tarpon Bay Partners LLC (the “Plaintiff”) in the Judicial District Court of Danbury, Connecticut. Plaintiff asserts that the Company failed to convert two convertible notes held by Plaintiff. The Company is vigorously contesting this claim. There are no other proceedings in which any of our directors, officers or affiliates, or any registered or beneficial stockholder, is an adverse party or has a material interest adverse to our interest.
 
The Company is subject to litigation, claims, investigations and audits arising from time to time in the ordinary course of business. Although legal proceedings are inherently unpredictable, the Company believes that it has valid defenses with respect to any matters currently pending against the Company and intends to defend itself vigorously. The outcome of these matters, individually and in the aggregate, is not expected to have a material impact on the Company’s cash flows, results of operations, or financial position.
 
NOTE 10 – FAIR VALUE MEASUREMENT
 
Fair value measurements
At March 31, 2020 and June 30, 2019, the fair value of derivative liabilities is estimated using the Cox, Ross & Rubinstein Binomial Tree valuation model using inputs that include the expected volatility, the implied risk-free interest rate, as well as the expected dividend rate. The derivative liabilities are the only Level 3 fair value measures.
  
 
18
 
 
VISIUM TECHNOLOGIES, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2020
 
NOTE 10 – FAIR VALUE MEASUREMENT, continued
 
At March 31, 2020 the estimated fair values of the liabilities measured on a recurring basis are as follows:
 
 
 
Fair Value Measurements at
 
 
 
 
(Level 1)
 
 
(Level 2)
 
 
(Level 3)
 
Derivative liability – Convertible notes
 $ 
 $ 
 $361,321 
Derivative liability – Warrants
  - 
  - 
  350 
Total derivative liability
 $- 
 $- 
 $361,671 
 
NOTE 11: SUBSEQUENT EVENTS
 
On May 7, 2020, Visium Technologies, Inc. (the “Company”), through its wholly owned subsidiary, Visium Analytics, LLC, entered into Amendment #1 (the “Amendment”) to the Software License Agreement with The MITRE Corporation (“MITRE”), a non-profit research organization serving the United States Government, originally entered into on March 27, 2019 (the “Agreement”). The Amendment provides the Company with exclusive rights to CyGraph®, a patented technology, from MITRE. CyGraph® is a cybersecurity application that provides machine learning acceleration, advanced cyber hunting, forensics, incident response and analytics (the “Software”). For the rights under the Amendment, the Company shall pay MITRE an exclusivity fee of $20,000 for the first year and $50,000 for the second year. Additionally, pursuant to the Amendment, the Company is required to have a marketable, demonstrable and saleable product or service using the Software within a specified time period, and the Company is required to pay to MITRE a royalty fee after the achievement of a certain milestone of sales of such product or service.
 
During April 2020 the Company issued 98,846,475 shares of its common stock related to the conversion of $26,726 of principal and accrued interest of its convertible notes payable, at an average contract conversion price of $0.00032 per share.
 
During May 2020 the Company issued 441,435,527 shares of its common stock related to the conversion of $46,164 of principal and accrued interest of its convertible notes payable, at an average contract conversion price of $0.00032 per share.
 
During June 2020 the Company issued 87,915,275 shares of its common stock related to the conversion of $17,756 of principal and accrued interest of its convertible notes payable, at an average contract conversion price of $0.00022 per share.
 
In April 2020 our consultants vested 66,667 shares of our $0.0001 par value common stock, valued at $4,000, or at an average price per share of $0.06.
 
In May 2020 our consultants vested 66,667 shares of our $0.0001 par value common stock, valued at $4,000, or at an average price per share of $0.06.
 
In June 2020 our consultants vested 66,667 shares of our $0.0001 par value common stock, valued at $4,000, or at an average price per share of $0.06.
 
In May 2020 the Company issued 500,000,000 shares of our $0.0001 par value common stock to consultants, officers, and directors, valued at $147,000, or an average price per share of $0.0003.
 
In June 2020 the Company generated proceeds of $30,000 through an amendment to each of the two convertible notes held by Auctus Funds, LLC and FirstFire Global Opportunites Fund, LLC to increase the principal balance on each note by $15,000.  No other changes were made to the terms or conditions of the original notes.
  
 
19
 
 
ITEM 2. Management’s Discussion and Analysis and Results of Operations
 
The following discussion of our financial condition and results of operations should be read in conjunction with the financial statements and related notes included elsewhere in this report. Certain statements in this discussion and elsewhere in this report constitute forward-looking statements. See ‘‘Cautionary Statement Regarding Forward Looking Information’’ elsewhere in this report. Because this discussion involves risk and uncertainties, our actual results may differ materially from those anticipated in these forward-looking statements.
 
Overview
 
Visium Technologies, Inc. is a Florida corporation with offices based in Fairfax, Virginia, focused on building a global cybersecurity business, by advancing technology and cybersecurity tools and services to support enterprises in protecting their most valuable assets - their data, on their networks, in the cloud, and Internet of Things (“IoT”).
 
Visium is a provider of cyber security automation, analytics and visualization. Visium operates in the traditional cyber security space, as well as in the cloud-based technology and Internet of Things (“IOT”) spaces. Visium provides cybersecurity technology solutions, tools and services to support commercial enterprises and governments ability to protect their data. Visium’s CyGraph technology provides visibility, advanced cyber monitoring intelligence, analytics and automation to help reduce risk, simplify cyber security and deliver better security outcomes.
 
In March 2019, Visium entered into a software license agreement with MITRE Corporation to license a patented technology, known as CyGraph, a tool for cyber warfare analytics, visualization and knowledge management. In May 2020 this license agreement was amended to grant the Company exclusive rights to this technology. CyGraph provides advanced visualization and analytics for cybersecurity situational awareness that is scalable, flexible and comprehensive.
 
Employees
 
At June 23, 2020, we had 3 full time employees.
 
Our principal offices are located at 4094 Majestic Lane Suite 360,Fairfax, VA 22033. Our telephone number is (703) 273-0383.
 
Our common stock is quoted on the OTC Pink under the symbol “VISM”.
  
 
20
 
 
VISIUM TECHNOLOGIES, INC.
RESULTS OF OPERATIONS
 
Three and Nine Month Periods Ended March 31, 2020 and 2019
 
 
 
Three Months Ended
 
 
Nine Months Ended
 
 
 
March 31,
 
   
 
   
 
2019
 
 
2020
 
 
2019
 
Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
 
Selling, general and administrative
 $189,675 
 $1,445,550 
 $604,439 
 $2,573,734 
Development expense
  - 
  - 
  35,500 
  - 
Amortization expense
  - 
  50,107 
    
  91,863 
Total Operating Expenses
  189,675 
  1,495,657 
  639,939 
  2,665,597 
 
    
    
    
    
Loss from Operations
  (189,675)
  (1,495,657)
  (639,939)
  (2,665,597)
 
    
    
    
    
Other income (expenses):
    
    
    
    
Gain (loss) on change in fair value of derivative liabilities
  (23,319)
  (536,549)
  462,249 
  (730,804)
Derivative liability expense
  - 
  (341,423)
  (61,396)
  (341,423)
Gain (loss) on settlement of debt
  (169,060)
  2,292,162 
  (267,881)
  2,303,147 
Other income
  - 
  10,000 
  - 
  10,000 
Interest expense
  (72,190)
  (121,592)
  (271,465)
  (233,194)
Total other income (expenses)
  (264,569)
  1,302,598 
  (138,493)
  1,007,726 
 
    
    
    
    
Net loss
 $(454,244)
 $(193,059)
 $(778,432)
 $(1,657,871)
 
Selling, General, and Administrative Expenses
 
Nine Month Period Ended March 31, 2020
 
For the nine months ended March 31, 2020, selling, general and administrative expenses were $604,439 as compared to $2,573,734 for the nine months ended March 31, 2019. For the nine month periods ended March 31, 2020 and 2019 selling, general and administrative expenses consisted of the following:
 
 
 
Nine Months Ended
 
 
   
 
   
 
2019
 
Accounting expense
 $5,382 
 $28,474 
Consulting fees
  82,250 
  97,500 
Salaries
  252,000 
  236,000 
Legal and professional fees
  27,050 
  71,330 
Travel expense
  9,786 
  3,137 
Occupancy expense
  4,719 
  7,867 
Telephone expense
  2,700 
  2,700 
Marketing expense
  8,199 
  - 
Website expense
  2,291 
  2,103 
Investor relations expense
  20,000 
  28,500 
Stock based compensation
  184,735 
  2,047,000 
Other
  5,327 
  49,123 
 
 $604,439 
 $2,573,734 
 
The decrease in selling, general and administrative expenses of $1,971,695 during fiscal 2020, when compared with the prior year, is primarily due to a decrease in stock-based compensation of $1,862,265, lower legal and professional fees of $44,280, lower other expenses of $43,796, lower accounting expense of $23,092, lower investor relations expense of $8,500, lower occupancy expense of $3,148, and lower consulting fees of $15,250, offset by higher salaries of $16,000, higher travel expense of $6,649, and higher marketing expense of $8,199.
 
We believe that our selling, general, and administrative expenses will remain steady as we increase our business activity over the remainder of 2020, but anticipate incurring lower legal and consulting expenses.
 
 
21
 
 
Development Expense
 
 
 
Nine-Months Ended
 
 
 
 
 
 
March 31,
 
 
%
 
 
 
2020
 
 
2019
 
 
Change
 
Development expense
 $35,500 
 $- 
  (100)%
 
Development expense represents the expense to further enhance and commercialize CyGraph. We believe that will incur an additional $50,000 of development expense during the remainder of fiscal 2020.
 
Amortization Expense
 
 
 
Nine-Months Ended
 
 
 
 
 
 
March 31,
 
 
%
 
 
 
2020
 
 
2019
 
 
Change
 
Customer relationships
 $- 
 $91,863 
  (100)%
 
The decrease in amortization expense is due to the amortization of the customer relationships intangible asset resulting from the acquisition of Threat Surface Solutions Group, LLC in October 2019.
 
Derivative Liability Expense
 
 
 
Nine-Months Ended
 
 
 
 
 
 
March 31,
 
 
%
 
 
 
2020
 
 
2019
 
 
Change
 
Derivative liability expense
 $61,396 
 $(341,423
  118%
Derivative liability expense represents the expense related to our convertible notes payable issued in October 2019 that include variable conversion features.
 
Change in Fair Value of Derivative Liabilities
 
 
 
Nine-Months Ended
 
 
 
 
 
 
March 31,
 
 
%
 
 
 
2020
 
 
2019
 
 
Change
 
Gain (loss) on change in fair value of derivative liabilities
 $462,249 
 $(730,804)
  163.3%
 
The change in fair value of derivative liabilities results from the changes in the fair value of the derivative liability due to the application of ASC 815, resulting in either income or expense, depending on the difference in fair value of the derivative liabilities between their measurement dates driven by the change in the per share price of the Company’s common stock.
 
 
22
 
 
Interest Expense
 
 
 
Nine-Months Ended
 
 
 
 
 
 
March 31,
 
 
%
 
 
 
2020
 
 
2019
 
 
Change
 
Interest expense
 $271,465 
 $233,194 
  16.4%
 
Interest expense represents stated interest of notes and convertible notes payable as well as amortization of debt discount. Interest expense is higher for the Nine Months Ended March 31, 2020 due to higher debt discount amortization as compared to the prior year period.
 
Gain (Loss) on Settlement of Debt
 
 
 
Nine-Months Ended
 
 
 
 
 
 
March 31,
 
 
%
 
 
 
2020
 
 
2019
 
 
Change
 
Gain (loss) on settlement of debt
 $(267,881)
 $2,303,147 
  (111.6)%
 
Three Month Period Ended March 31, 2020
 
For the three months ended March 31, 2020, selling, general and administrative expenses were $189,675 as compared to $691,157 for the three months ended March 31, 2019. For the three months ended March 31, 2020 and 2019 selling, general and administrative expenses consisted of the following:
 
 
 
Three Months Ended
 
 
   
 
   
 
2019
 
Accounting expense
 $398 
 $5,724 
Consulting fees
  27,500 
  46,250 
Salaries
  84,000 
  84,000 
Legal and professional fees
  10,500 
  37,040 
Travel expense
  - 
  357 
Occupancy expense
  1,582 
  1,968 
Telephone expense
  900 
  900 
Website expense
  760 
  145 
Stock based compensation
  63,735 
  1,266,958 
Other
  300 
  2,208 
 
 $189,675 
 $1,445,550 
 
The decrease in selling, general and administrative expenses of $1,258,275 during the fiscal third quarter of 2020, when compared with the prior year, is primarily due to a decrease in stock-based compensation of $1,258,275, lower legal and professional fees of $26,540, lower other expenses of $1,908, lower accounting expense of $5,326, lower occupancy expense of $386, and lower consulting fees of $18,750, offset by higher website expense of $615.
 
Amortization Expense
 
 
 
Three-Months Ended
 
 
 
 
 
 
March 31,
 
 
%
 
 
 
2020
 
 
2019
 
 
Change
 
Customer relationships
 $- 
 $50,107 
  100%
 
Amortization expense in the prior year is due to the amortization of the customer relationships intangible asset resulting from the acquisition of Threat Surface Solutions Group, LLC in October 2019.
 
Change in Fair Value of Derivative Liabilities
 
 
 
Three-Months Ended
 
 
 
 
 
 
March 31,
 
 
%
 
 
 
2020
 
 
2019
 
 
Change
 
Gain (loss) on change in fair value of derivative liabilities
 $(23,319)
 $536,549 
  (104.3)%
 
The change in fair value of derivative liabilities results from the changes in the fair value of the derivative liability due to the application of ASC 815, resulting in either income or expense, depending on the difference in fair value of the derivative liabilities between their measurement dates driven by the change in the per share price of the Company’s common stock.
 
 
23
 
 
Interest Expense
 
 
 
Three-Months Ended
 
 
 
 
 
 
March 31,
 
 
%
 
 
 
2020
 
 
2019
 
 
Change
 
Interest expense
 $72,190 
 $121,592 
  (40.6)%
 
Interest expense represents stated interest of notes and convertible notes payable as well as amortization of debt discount. Interest expense is higher for the three months ended March 31, 2020 due to higher debt discount amortization as compared to the prior year period.
 
Derivative Liability Expense
 
 
 
Three-Months Ended
 
 
 
 
 
 
March 31,
 
 
%
 
 
 
2020
 
 
2019
 
 
Change
 
Derivative liability expense
 $- 
 $341,323 
  100%
 
Gain (Loss) on Settlement of Debt
 
 
 
Three-Months Ended
 
 
 
 
 
 
March 31,
 
 
%
 
 
 
2020
 
 
2019
 
 
Change
 
Gain (loss) on settlement of debt
 $(169,060)
 $2,292,162 
  (107.4)%
 
Liquidity and Capital Resources
 
 
 
Balance at
 
 
Cash
 $326 
 $18,668 
Accounts payable and accrued expenses
  282,376 
  213,805 
Accrued compensation
  568,529 
  316,529 
Notes, convertible notes, and accrued interest payable
 $1,911,768 
 $1,863,898 
 
We do not have any material commitments for capital expenditures.
 
The objective of liquidity management is to ensure that we have ready access to sufficient funds to meet commitments and effectively implement our growth strategy. Our primary sources are financing activities such as the issuance of notes payable and convertible notes payable. In the past, we have mostly relied on debt and equity financing to provide for our operating needs.
 
We cannot ascertain that we have sufficient funds from operations to fund our ongoing operating requirements through June 30, 2020. We may need to raise funds to enhance our working capital and use them for strategic purposes. If such need arises, we intend to generate proceeds from either debt or equity financing.
 
We intend to finance our operations using a mix of equity and debt financing. We do not anticipate incurring capital expenditures for the foreseeable future. We anticipate that we will need to raise approximately $180,000 per year in the near term to finance the recurring costs of being a publicly-traded company. If these funds cannot be obtained our business may fail as a result.
 
Going Concern
 
The accompanying financial statements have been prepared on a going concern basis. The Company has net cash used in its operating activities of $106,181 and $491,014 during the nine-month periods ended March 31, 2020 and 2019, respectively, and has a working capital deficit of approximately $3.1 million and $3.2 million at March 31, 2020 and June 30, 2019, respectively. The Company’s ability to continue as a going concern is dependent upon its ability to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due, to fund possible future acquisitions, and to generate profitable operations in the future, once a merger with an operating company is consummated. Management plans may continue to provide for its capital requirements by issuing additional equity securities and debt and the Company will continue to find possible acquisition target. The outcome of these matters cannot be predicted at this time and there are no assurances that if achieved, the Company will have sufficient funds to execute its business plan or generate positive operating results.
 
 
24
 
 
Nine Months Ended March 31, 2020
 
Net cash used in operations during the nine months ended March 31, 2020 decreased by approximately $384,833 or 78% from the same period during fiscal year 2019. The decrease in cash used in operations is primarily due to the decrease in consulting and business development expense and cash paid for legal and professional fees, and the decrease in cash paid for salaries to executives. This cash was obtained through the sale of a convertible note that netted the Company $48,000, and through advances of cash made to the Company by its officers and directors of $39,840.
 
Nine Months ended March 31, 2019
 
Net cash used in operations during the nine months ended March 31, 2019 increased by $446,000 or 751% from the same period during fiscal year 2018. The increase in cash used in operations is primarily due to the increase in consulting and business development expense and cash paid for legal and professional fees of $97,250, and the increase in cash paid for salaries to executives of $23,200, offset by the decrease in cash paid for audit and related services of $9,000. This cash was obtained through the sale of 2,505,500 shares of the Company’s $0.0001 par value common stock, at a per share price of $0.10, or $250,500, and the sale of convertible notes totaling $300,000.
 
Capital Raising Transactions
 
Issuance of convertible notes payable
 
We generated net proceeds of $48,000 from the issuance of a convertible note payable during the nine-month period ended March 31, 2020.
 
Other outstanding obligations at March 31, 2020
 
Convertible Notes Payable
 
The Company had convertible promissory notes aggregating $928,000 outstanding at March 31, 2020. The accrued interest amounted to approximately $510,000 as of March 31, 2020. The Convertible Notes Payable bear interest at rates ranging between 0% and 18% per annum. Interest is generally payable monthly. The Convertible Notes Payable are generally convertible at rates ranging between $0.0003 and $0.60 per share, at the holders’ option. At March 31, 2020, $890,000 of the promissory notes have matured.
 
Convertible notes payable to ASC Recap LLC
 
On July 22, 2013 and May 6, 2014, the Company issued to ASC Recap LLC (“ASC”) two convertible promissory notes with principal amounts of $25,000 and $125,000, respectively. These two notes were issued as a fee for services under a 3(a)10 transaction that was never consummated and therefore there was no performance by ASC to earn the notes. As a result, while the Company continues to carry the balance of these notes on its balance sheet, it does not believe the notes payable balances are owed. The July 22, 2013 note matured on March 31, 2014 and a balance of $22,965 remains unpaid. The May 6, 2014 note matured on May 6, 2016 and remains unpaid. The notes are convertible into the common stock of the Company at any time at a conversion price equal to 50% of the lowest closing bid price of our common stock for the twenty days prior to conversion.
 
Notes Payable
 
The Company had promissory notes aggregating $205,000 at March 31, 2020. The related accrued interest amounted to approximately $171,000 at March 31, 2020. The Notes Payable bear interest at rates ranging between 8% and 16% per annum. Interest is generally payable monthly. All promissory notes have matured as of March 31, 2020.
 
 
25
 
 
Off-Balance Sheet Arrangements
 
We have no off-balance sheet arrangements.
 
Item 3. Quantitative and Qualitative Disclosures About Market Risk
 
Not applicable to a smaller reporting company.
 
Item 4. Controls and Procedures
 
Evaluation of Disclosure Controls and Procedures
 
Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. Our management assessed the effectiveness of our internal control over financial reporting as of March 31, 2020. In making this assessment, our management used criteria issued by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control Over Financial Reporting – Guidance for Smaller Public Companies.
 
During our assessment of the design and the effectiveness of internal control over financial reporting as of March 31, 2020, management identified the following material weaknesses:
 
 
While we have processes in place, there are no formal written policies and procedures related to certain financial reporting processes;
 
 
 
 
There is no formal documentation in which management specified financial reporting objectives to enable the identification of risks, including fraud risks;
 
 
 
 
Our Board of Directors consisted of four members, however we lack the resources and personnel to implement proper segregation of duties or other risk mitigation systems.
 
A material weakness is “a significant deficiency, or a combination of significant deficiencies, that result in more than a remote likelihood that a material misstatement of the annual or interim financial statements will not be prevented or detected by us in a timely manner.” A significant deficiency is a deficiency or a combination of deficiencies, in internal control over financial reporting that is less severe than a material weakness, yet important enough to merit attention by those responsible for oversight of the registrant’s financial reporting.
 
We intend to gradually improve our internal control over financial reporting to the extent that we can allocate resources to such improvements. We intend to prioritize the design of our internal control over financial reporting starting with our control environment and risk assessments and ending with control activities, information and communication activities, and monitoring activities. Although we believe the time to adapt in the next year will help position us to provide improved internal control functions into the future, in the interim, these changes caused control deficiencies, which in the aggregate resulted in a material weakness. Due to the existence of these material weaknesses, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that our internal control over financial reporting was not effective as of March 31, 2020.
 
This annual report does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s independent registered public accounting firm pursuant to the rules of the SEC that permit smaller reporting companies to provide only the management’s report in this annual report.
 
Changes in Internal Control Over Financial Reporting
 
During the quarter ended March 31, 2020, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
 
26
 
 
PART II - OTHER INFORMATION
 
Item 1. Legal Proceedings.
 
With the exception of the item described below, at March 31, 2020 the Company is not the subject of, or party to, any pending or threatened, legal actions.
 
In July 2018 the Company was named as the defendant in a legal proceeding brought by Tarpon Bay Partners LLC (the plaintiff) in the Judicial District Court of Danbury, Connecticut. The plaintiff asserts that the Company failed to convert two convertible notes held by the Plaintiff. The Company is vigorously contesting this claim.
 
From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.
 
Item 1A. Risk Factors.
 
In addition to the other information set forth in this report, you should carefully consider the factors discussed under the heading “Risk Factors” in our Annual Report on Form 10-K filed on September 27, 2019, which could materially affect our business operations, financial condition or future results. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business operations and/or financial condition. There have been no material changes to our risk factors since the filing of our Form 10-K.
 
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
 
During the nine months ended March 31, 2020 the Company issued 234,213,241 shares of its common stock related to the conversion of $223,679 of principal and accrued interest of its convertible notes payable, at an average contract conversion price of $0.000954 per share.  The fair value of these shares was $612,456
 
During the nine months ended March 31, 2020 the Company issued 19,650,000 shares of its $0.0001 par value common stock to five consultants, as compensation. The shares were valued at $132,735, or $0.0068 per share.
 
During the nine months ended March 31, 2020 the Company issued 28,000,000 shares of its $0.0001 par value common stock to one of its directors as compensation for services rendered. The shares were valued at $52,000, or $0.0019 per share.
 
Item 3. Defaults Upon Senior Securities.
 
None
 
Item 4. Mine Safety Disclosures.
 
Not applicable to our operations.
 
Item 5. Other Information.
 
None
 
Item 6. Exhibits
 
31.1
Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
 
 
31.2
Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
 
 
32.1
Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 *
 
 
32.2
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 *
 
*
Filed herewith.
 
 
27
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
VISIUM TECHNOLOGIES, INC.
 
 
 
 
By:
 
Mark B. Lucky
 
 
CEO, principal executive officer
 
 
 
 
By:
 
Mark Lucky
 
 
CFO, principal accounting officer
 
 

 
 
 
28

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
10/12/21
Corrected on:7/7/20
6/30/20
Filed on / Changed on:6/29/20
6/27/20
6/23/20
5/7/208-K
For Period end:3/31/20
3/25/20
3/13/20
3/11/20
12/31/1910-Q
12/30/19
9/27/1910-K
6/30/1910-K
3/31/1910-Q,  10-Q/A
3/27/19
12/31/1810-Q
7/1/18
6/30/1810-K
5/6/1610-Q/A
5/6/14
3/31/1410-Q
7/22/13
6/30/0810-K,  10-K/A,  NTN 10K
 List all Filings 
Top
Filing Submission 0001654954-20-007085   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 7:51:33.1am ET